Si Bone News Today

SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) insider Anthony J. Recupero sold 3,307 shares of the company’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $15.50, for a total transaction of $51,258.50. Following the completion of the sale, the insider now directly owns 252,453 […]

SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) insider Anthony J. Recupero sold 3,307 shares of the firm’s stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $15.50, for a total transaction of $51,258.50. Following the completion of the sale, the insider now owns 252,453 shares of the […]

SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) insider Anthony J. Recupero sold 3,307 shares of SI-BONE stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $15.50, for a total value of $51,258.50. Following the completion of the transaction, the insider now owns 252,453 shares of the company’s […]

SI-BONE (NASDAQ:SIBN – Get Free Report)‘s stock had its “overweight” rating reissued by equities researchers at Cantor Fitzgerald in a report released on Tuesday, Benzinga reports. They currently have a $25.00 target price on the stock. Cantor Fitzgerald’s price objective suggests a potential upside of 36.76% from the company’s previous close. A number of other […]

Spine devicemaker SI-Bone saw $138.9 million in revenue in 2023, the company said Feb. 26.

By Sabela Ojea Shares of SI-BONE on Tuesday dropped a day after the company posted a wider-than-expected loss in the latest quarter. At 12:23 p.m. ET, shares...

Moody Aldrich Partners LLC lifted its position in SI-BONE, Inc. (NASDAQ:SIBN – Free Report) by 4.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 171,748 shares of the company’s stock after acquiring an additional 6,823 shares during the period. Moody […]

SANTA CLARA, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to...

By Rob Curran Shares of SI-Bone rose after the medical-device maker received clearance from the Food and Drug Administration to market its bone-implant...

SI-Bone earned FDA 510(k) clearance of the iFuse Bedrock Granite implant system in a smaller diameter, according to a Jan. 30 news release.